Christoph A. Gebeshuber
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Computational drug repositioning of clopidogrel as a novel therapeutic option for focal segmental glomerulosclerosis.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: October 21, 2022
ECM Characterization Reveals a Massive Activation of Acute Phase Response during FSGS.
Journal: International journal of molecular sciences
Published: February 09, 2020
Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS.
Journal: PloS one
Published: November 01, 2019
A systems pharmacology workflow with experimental validation to assess the potential of anakinra for treatment of focal and segmental glomerulosclerosis.
Journal: PloS one
Published: December 14, 2018
MicroRNA-193a Regulates the Transdifferentiation of Human Parietal Epithelial Cells toward a Podocyte Phenotype.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 19, 2014
Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1.
Journal: Nature medicine
Published: October 24, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026